Secondary Degeneration Impairs Myelin Ultrastructural Development in Adulthood following Adolescent Neurotrauma in the Rat Optic Nerve.
CNS injury
axon
myelin
neurodevelopment
oligodendrocyte
transmission electron microscopy
ultrastructure
white matter
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
07 Feb 2023
07 Feb 2023
Historique:
received:
16
12
2022
revised:
31
01
2023
accepted:
01
02
2023
entrez:
25
2
2023
pubmed:
26
2
2023
medline:
3
3
2023
Statut:
epublish
Résumé
Adolescence is a critical period of postnatal development characterized by social, emotional, and cognitive changes. These changes are increasingly understood to depend on white matter development. White matter is highly vulnerable to the effects of injury, including secondary degeneration in regions adjacent to the primary injury site which alters the myelin ultrastructure. However, the impact of such alterations on adolescent white matter maturation is yet to be investigated. To address this, female piebald-virol-glaxo rats underwent partial transection of the optic nerve during early adolescence (postnatal day (PND) 56) with tissue collection two weeks (PND 70) or three months later (PND 140). Axons and myelin in the transmission electron micrographs of tissue adjacent to the injury were classified and measured based on the appearance of the myelin laminae. Injury in adolescence impaired the myelin structure in adulthood, resulting in a lower percentage of axons with compact myelin and a higher percentage of axons with severe myelin decompaction. Myelin thickness did not increase as expected into adulthood after injury and the relationship between the axon diameter and myelin thickness in adulthood was altered. Notably, dysmyelination was not observed 2 weeks postinjury. In conclusion, injury in adolescence altered the developmental trajectory, resulting in impaired myelin maturation when assessed at the ultrastructural level in adulthood.
Identifiants
pubmed: 36834755
pii: ijms24043343
doi: 10.3390/ijms24043343
pmc: PMC9966883
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
J Neural Transm (Vienna). 2010 May;117(5):639-54
pubmed: 20107844
J Cereb Blood Flow Metab. 2014 Apr;34(4):715-23
pubmed: 24473478
Neurosurgery. 2014 Oct;75 Suppl 4:S24-33
pubmed: 25232881
Neuroimage. 2017 Jun;153:122-130
pubmed: 28377211
PLoS One. 2013 Jun 19;8(6):e66448
pubmed: 23840470
J Neurosci. 2011 Jul 27;31(30):10937-47
pubmed: 21795544
Neuroscience. 2001;104(1):235-51
pubmed: 11311546
Invest Ophthalmol Vis Sci. 2003 Aug;44(8):3388-93
pubmed: 12882786
Dev Neurobiol. 2022 May;82(4):308-325
pubmed: 35403346
Neuroimage. 2007 Apr 1;35(2):501-10
pubmed: 17258911
Semin Fetal Neonatal Med. 2006 Dec;11(6):489-97
pubmed: 16962837
J Neurochem. 2019 Jun;149(5):660-678
pubmed: 30702755
Neuroimage. 2008 Apr 15;40(3):1044-55
pubmed: 18295509
Cereb Cortex. 2005 Dec;15(12):1848-54
pubmed: 15758200
Neuroscience. 2014 Sep 12;276:126-34
pubmed: 23820043
Exp Neurol. 2006 Apr;198(2):350-60
pubmed: 16448652
Dev Neurosci. 2006;28(4-5):302-8
pubmed: 16943653
Neuroscience. 1994 Nov;63(1):135-49
pubmed: 7898644
J Neurotrauma. 2011 Jun;28(6):1077-88
pubmed: 21381867
Brain Res. 1995 Dec 8;702(1-2):1-16
pubmed: 8846063
Sci Rep. 2019 Oct 25;9(1):15297
pubmed: 31653948
J Neurosci. 1996 Aug 15;16(16):5095-105
pubmed: 8756439
J Neurotrauma. 2010 Feb;27(2):439-52
pubmed: 19852581
J Neurochem. 1996 Sep;67(3):1014-22
pubmed: 8752107
Physiol Rev. 2001 Apr;81(2):871-927
pubmed: 11274346
Nat Neurosci. 1999 Oct;2(10):859-61
pubmed: 10491602
J Neurosci. 2007 Aug 29;27(35):9525-33
pubmed: 17728465
Sci Rep. 2018 Mar 5;8(1):3979
pubmed: 29507421
Exp Neurol. 2020 Apr;326:113167
pubmed: 31904385
Neuroimage. 2010 Jan 1;49(1):94-103
pubmed: 19679191
Hum Brain Mapp. 2020 Feb 15;41(3):827-839
pubmed: 31661180
Amino Acids. 2012 May;42(5):2031-5
pubmed: 21547361
Invest Ophthalmol Vis Sci. 2009 Nov;50(11):5456-62
pubmed: 19474405
Front Psychiatry. 2022 May 10;13:876793
pubmed: 35619614
Nat Neurosci. 1999 Oct;2(10):861-3
pubmed: 10491603
EXCLI J. 2021 Sep 23;20:1431-1445
pubmed: 34737685
Neuropharmacology. 2013 Dec;75:380-90
pubmed: 23958451
PLoS One. 2013 Jun 11;8(6):e65710
pubmed: 23776532
Acta Neuropathol Commun. 2020 Nov 12;8(1):193
pubmed: 33183353
Neurosci Lett. 1995 Aug 4;195(2):93-6
pubmed: 7478276
Graefes Arch Clin Exp Ophthalmol. 2011 Jun;249(6):849-57
pubmed: 21229256
J Neuropathol Exp Neurol. 2012 Mar;71(3):198-210
pubmed: 22318124
Invest Ophthalmol Vis Sci. 2012 Sep 04;53(10):6093-101
pubmed: 22879411
Neuroimage. 2008 Aug 15;42(2):1032-44
pubmed: 18602840
Nat Rev Neurosci. 2008 Dec;9(12):947-57
pubmed: 19002191
Prog Neurobiol. 2013 Jul-Aug;106-107:1-16
pubmed: 23583307
Biol Mood Anxiety Disord. 2013 Dec 02;3(1):21
pubmed: 24289263
J Neurosci. 2018 Jul 18;38(29):6491-6504
pubmed: 29915135
Lancet Neurol. 2019 Jan;18(1):24-25
pubmed: 30497967
Exp Brain Res. 2019 Jan;237(1):161-171
pubmed: 30367192
Hum Brain Mapp. 2020 Aug 15;41(12):3392-3402
pubmed: 32432383
Exp Neurol. 2009 Mar;216(1):219-30
pubmed: 19118550
J Neuropathol Exp Neurol. 2009 Jul;68(7):797-808
pubmed: 19535992
Neuron. 2001 Apr;30(1):91-104
pubmed: 11343647
Dev Sci. 2013 Nov;16(6):941-51
pubmed: 24118718
PLoS One. 2013 Dec 10;8(12):e81339
pubmed: 24339917
J Neurosci. 2009 Sep 16;29(37):11614-8
pubmed: 19759308
BMC Neurosci. 2010 Aug 13;11:97
pubmed: 20707883
J Neurochem. 2010 Mar;112(5):1147-55
pubmed: 19968758
BMC Neurosci. 2013 Sep 08;14:98
pubmed: 24011177
Pediatr Radiol. 2013 Jan;43(1):15-27
pubmed: 23288475
J Neurosci Res. 2012 Mar;90(3):606-18
pubmed: 22038561
J Exp Neurosci. 2018 Nov 14;12:1179069518810004
pubmed: 30479489
Neuroimage. 2012 Mar;60(1):340-52
pubmed: 22178809
Neuroimage. 2021 Feb 15;227:117678
pubmed: 33359342
Neuroimage. 2018 Nov 15;182:343-350
pubmed: 28916179
J Neurosci Res. 2002 Nov 15;70(4):588-98
pubmed: 12404513
NMR Biomed. 2002 Nov-Dec;15(7-8):435-55
pubmed: 12489094